panitumumab,bevacizumab
amgen,takeda,roche
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
#asco2022 #mlmasco - japanese trial: improved os in left-sided wtras-mcrc with pani-folfox vs bev-folfox in 1l. dr. cremolini s (discussant) algorithm 
"What we cannot speak about we must pass over in silence" (L. Wittgenstein)